Quadrant Capital Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Sell
5,772
-14
-0.2% -$2.91K 0.04% 454
2026
Q1
$1.22M Buy
5,786
+538
+10% +$116K 0.04% 478
2025
Q4
$1.08M Buy
5,248
+267
+5% +$50.2K 0.03% 507
2025
Q3
$782K Buy
4,981
+41
+0.8% +$6.33K 0.03% 634
2025
Q2
$830K Buy
4,940
+2,038
+70% +$302K 0.03% 580
2025
Q1
$400K Buy
2,902
+1,404
+94% +$179K 0.01% 896
2024
Q4
$177K Sell
1,498
-23
-2% -$2.69K 0.01% 751
2024
Q3
$168K Sell
1,521
-14
-0.9% -$1.46K 0.01% 790
2024
Q2
$151K Buy
1,535
+447
+41% +$45.5K 0.01% 795
2024
Q1
$122K Buy
1,088
+38
+4% +$4.1K 0.01% 897
2023
Q4
$106K Buy
1,050
+35
+3% +$3.47K 0.01% 960
2023
Q3
$88.1K Buy
1,015
+226
+29% +$20.4K 0.01% 949
2023
Q2
$74.6K Sell
789
-41
-5% -$3.46K 0.01% 1041
2023
Q1
$62.7K Buy
830
+100
+14% +$7.54K 0.01% 1101
2022
Q4
$56.1K Buy
730
+11
+2% +$836 0.01% 1105
2022
Q3
$48K Sell
719
-169
-19% -$10.7K 0.01% 1063
2022
Q2
$46K Buy
888
+104
+13% +$5.91K 0.01% 904
2022
Q1
$44K Sell
784
-40
-5% -$2.14K 0.01% 975
2021
Q4
$42K Sell
824
-578
-41% -$28.3K 0.01% 989
2021
Q3
$69K Sell
1,402
-106
-7% -$5.75K 0.01% 742
2021
Q2
$86K Buy
1,508
+40
+3% +$2.34K 0.01% 656
2021
Q1
$89K Buy
1,468
+180
+14% +$9.94K 0.01% 611
2020
Q4
$69K Sell
1,288
-95
-7% -$4.93K 0.01% 636
2020
Q3
$65K Sell
1,383
-2,539
-65% -$130K 0.01% 575
2020
Q2
$205K Buy
3,922
+1,048
+36% +$54K 0.05% 267
2020
Q1
$137K Buy
2,874
+1,757
+157% +$91.2K 0.02% 475
2019
Q4
$49K Buy
1,117
+92
+9% +$4.75K 0.01% 1341
2019
Q3
$46K Sell
1,025
-490
-32% -$22.4K 0.01% 1249
2019
Q2
$68K Sell
1,515
-1,161
-43% -$53.6K 0.01% 1062
2019
Q1
$123K Buy
2,676
+1,301
+95% +$65.2K 0.02% 698
2018
Q4
$55K Sell
1,375
-412
-23% -$21.5K 0.01% 851
2018
Q3
$90K Buy
1,787
+178
+11% +$9.11K 0.03% 442
2018
Q2
$74K Sell
1,609
-148
-8% -$8.39K 0.03% 511
2018
Q1
$105K Buy
1,757
+47
+3% +$3.22K 0.04% 394
2017
Q4
$101K Buy
1,710
+29
+2% +$1.79K 0.04% 397
2017
Q3
$109K Sell
1,681
-60
-3% -$4.24K 0.05% 359
2017
Q2
$123K Sell
1,741
-231
-12% -$17.4K 0.05% 298
2017
Q1
$156K Buy
1,972
+116
+6% +$9.13K 0.07% 236
2016
Q4
$130K Sell
1,856
-50
-3% -$3.62K 0.07% 209
2016
Q3
$142K Buy
1,906
+44
+2% +$3.56K 0.09% 180
2016
Q2
$140K Sell
1,862
-35
-2% -$2.79K 0.1% 178
2016
Q1
$152K Buy
1,897
+37
+2% +$3.01K 0.1% 165
2015
Q4
$162K Sell
1,860
-11
-0.6% -$934 0.11% 159
2015
Q3
$142K Sell
1,871
-457
-20% -$38.2K 0.1% 172
2015
Q2
$191K Buy
+2,328
New +$206K 0.12% 143

Other funds holding CAH

Quadrant Capital Group's CAH Position: Q2 2026 in Review

Quadrant Capital Group reduced its Cardinal Health (CAH) stake by 0.24% in Q2 2026, selling an estimated $2.91K and leaving 5,772 shares worth $1.37M. The position accounts for 0.04% of the portfolio, ranked #454.

Quadrant Capital Group first reported a position in CAH in Q2 2015 and has held it in 45 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Quadrant Capital Group held 5,772 shares of Cardinal Health worth $1.37M as of Q2 2026.
  • Quadrant Capital Group sold 14 Cardinal Health shares in Q2 2026, an estimated $2.91K.
  • Cardinal Health made up 0.04% of Quadrant Capital Group's portfolio in Q2 2026, its #454 holding.
  • Quadrant Capital Group first reported a position in Cardinal Health in Q2 2015 and has held it in 45 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.